Notice ID: 683280c57ecc44408b58838bc7f42c49Presolicitation
Aldevron Ebola Plasmid Synthesis
Archived on September 26, 2020. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM UTC−04:00
- Posted
- September 2, 2020
- Notice type
- Presolicitation
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIAID
- Place of performance
- Bethesda, MD, 20892
- Last updated
- Apr 29, 2026
Identifiers
- Solicitation number
- NOI-NIAID-2032802
- Notice ID
- 683280c57ecc44408b58838bc7f42c49
Description
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on other than full and open competition basis with Aldevron, Fargo, ND 58104 Ebola Plasmid Synthesis. The Biodefense Research Section (BRS) of the Vaccine Research Center (VRC) utilizes plasmid constructs which encode for the viral protein (GP) for all three species of the Ebola virus. The plasmid is used to transfect human cells, to produce GP supernatant product, which is used as the coating antigen for all standard BRS ELISAs. The coating antigen that is produced from the plasmids is critical for eliciting antibody responses from NHP and human serum samples that give light to the effectiveness of the programs vaccine strategies. Plasmids synthesized by Aldevron are used to produce a critical reagent that is required for all standard BRS ELISAs. These ELISAs play a crucial role in informing important decisions made regarding Ebola virus vaccine development. Therefore, to bridge current findings to historical data the same plasmid must be used otherwise all our current data will not be bridgeable to historical data, deeming current data uninterpretable and hindering the progression of Ebola vaccine development efforts. No Substitutions are allowed on this project. FAR Provisions that apply: FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Dec 2019) FAR 52.212-1 Instructions to Offerors Commercial Items (Jun 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Aug 2020) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements Representation (Jan 2017) FAR 52.212-3 Offerors Representations and Certifications- Commercial Items FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) The Place of performance is 5625 Fishers Lane Rockville, MD 20852. The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR QUOTES. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2032802) to Ms. Skye Duffner at skye.duffner@nih.gov by 10:00 am eastern standard time, September 11, 2020. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
NOI-NIAID-2032802- Pre-Solicitation
Formal solicitation typically follows within 30–60 days. (estimate)
- Pre-SolicitationCurrentSep 2, 2020
Aldevron Ebola Plasmid Synthesis
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
NOI-NIAID-2032802
Archive Date
Sep 26, 2020
Office Address
BETHESDA, MD, 20892